FDA

RSS

Domestic sales of medically important antibiotics for use in food-producing chicken, turkey, cattle, and swine fell by 2 percent in 2023, according to the latest report from the U.S. Food and Drug Administration (FDA).

The regulation of food science innovations is complicated by the vast number of agencies and departments overseeing food in the U.S. This article argues for a “clean-up” of the current regulatory scheme, as disparate funding and priorities create inconsistency, food safety risks, and poor enforcement outcomes.

The In-Q Knowledge Center for FDA Compliance is a new platform designed to streamline compliance for U.S. Food and Drug Administration (FDA)-regulated manufacturers and importers.

This article focuses on one of the three branches within the newly created U.S. Food and Drug Administration (FDA) Human Foods Program—the Office of Food Chemical Safety, Dietary Supplements, and Innovation—and its potential impact on food packaging.

Bimbo Bakeries’ response letter to an FDA warning letter about intentionally adding sesame to its products and falsely listing sesame as an ingredient on products has been revealed by consumer protection groups. In short, the company defended its practice. 

U.S. Senators Edward Markey and Cory Booker recently wrote a letter to the U.S. Food and Drug Administration (FDA) urging the agency to revoke its authorization for phthalates in food contact materials, arguing that the chemicals are proven to be toxic. 

The U.S. Food and Drug Administration (FDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Department of Agriculture (USDA) have released an online tool to help biotechnology companies better understand the regulatory requirements for genetically modified organisms (GMOs).

On October 1—the first effective date of the U.S. Food and Drug Administration’s Human Foods Program (FDA’s HFP), as the agency begins implementing its reorganized structure—the HFP introduced a streamlined approach for processing complaints from the public about foods and dietary supplements.

In February 2024, FDA clarified the regulatory pathway for human and animal foods produced from genome-edited plants in a final guidance titled Foods Derived from Plants Produced Using Genome Editing: Guidance for Industry.

Small and midsized businesses striving for full compliance with the Preventive Controls for Human Food Rule (PCHF Rule) average $22,000 in upfront costs and $8,000 in every subsequent year, one study suggests.